Financial report is a formal document, commonly issued at the turn of an accounting period and containing a structurally presented description of a company’s financial activities and results. A financial report usually covers a financial position, equity changes and provides company’s balance sheet, income and cash flow statements.
Financial reports represent a reliable as well as relevant source of data used to support businesses in the decision making process. Financial reports can be prepared both for internal (for the company’s employees and owners) and external use (for present and potential investors, lenders, shareholders, etc.).
This MarketPublishers’ catalogue provides a great plenitude of the financial reports of various companies. The researches offer detailed examination of a company’s strategic and operational performance as well as scrutinize the investment climate; review the business divisions; present SWOT analyses; list company’s products and services. The reports contain brief overviews of companies’ historic background and include clear pictures of the companies’ actual market positions.
Publications found:
9,254
Sort by:
The 2011 Leading Life Science Intermediates Companies Collaborations
US$ 1,480.00
Global PDF: US$ 3,900.00 For each company, the report presents: Major joint venture, distribution, OEM and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, ...
October 2010
70 pages
The 2011 Leading Life Science Intermediates Companies Financial Analyses
US$ 1,480.00
Global PDF: US$ 3,900.00 Each company’s analysis provides: Sales and operating profit by division, product line, geographic region and country. Five-year sales and profit performance. The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep ...
October 2010
105 pages
The 2011 Leading Life Science Intermediates Companies Organizations and Management
US$ 1,480.00
Global PDF: US$ 3,900.00 For each company, the report provides: History of the life science intermediates business evolution, important to the understanding of the corporate culture, management mentality and strategies. Recent acquisitions, divestitures and significant organizational changes. Current ...
October 2010
110 pages
The 2011 Leading Life Science Intermediates Companies Product Portfolio Analyses
US$ 1,480.00
Global PDF: US$ 3,900.00 For each company, the analyses present: Extensive review of the major product lines. New product introductions and line extensions. The companies analyzed in the report: BASF, Bayer/Lanxess, Cambrex, Clariant, DowPharma, DSM, Evonik, Lonza, Novasep, and Rhodia. Contains 57 ...
October 2010
57 pages
